Efficient, glucose responsive and islet-specific transgene expression by a modified rat insulin promoter

Gene Therapy

Volumn 16, Issue 10, 2009, Pages 1202-1209

  Chai, R ^a   Chen, S ^a   Ding, J ^a   Grayburn, P A ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GLUCOSE; INSULIN; LUCIFERASE; PROTEIN DSRED; UNCLASSIFIED DRUG;

ACINAR CELL; ALPHA CELL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DESTRUCTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DUCTAL CELL; EXOCRINE CELL; FIBROBLAST; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INS1 CELL; MICROTUBULE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; RAT; RAT INSULIN PROMOTER; REPORTER GENE; TRANSGENE; ULTRASOUND TARGETED MICROTUBULE DESTRUCTION;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; LUCIFERASES; MICROBUBBLES; MICROSCOPY, CONFOCAL; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSGENES;

RATTUS;

EID: 70350187073     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2009.114     Document Type: Article

References (36)

1. Newgard CB. While tinkering with the β-cell metabolic regulatory mechanisms and new therapeutic strategies: American Diabetes Association Lilly Lecture, 2001. Diabetes 2002; 51: 3141-3150.
2. Bonner-Weir S, Weir GC. New sources of pancreatic β-cells. Nat Biotechnol 2005; 23: 857-861.
3. Samson SL, Chan L. Gene therapy for diabetes: Reinventing the islet. Trends Endocrinol Metab 2006; 17: 92-100.
4. McClane SJ, Chirmule N, Burke CV, Raper SE. Caracterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration. Human Gene Ther 1997; 8: 2207-2216.
5. Ayuso E, Chillon M, Agudo J, Haurigot V, Bosch A, Carretero A et al. In vivo gene transfer to pancreatic beta cells by systemic delivery of adenoviral vectors. Human Gene Ther 2004; 15: 805-812.
6. Wang AY, Peng PD, Ehrhardt A, Storm TA, Kay MA. Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo. Human Gene Ther 2004; 15: 405-413.
7. Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854-11859.
8. Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol 2004; 78: 6381-6388.
9. Wang Z, Ma HI, Li J, Sun L, Zhang J, Xiao X. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Therapy 2003; 10: 2105-2111.
10. McCarty DM, Fu H, Monahan PE, Toulson CE, Naik P, Samulski RJ. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Therapy 2003; 10: 2112-2118.
11. Chen S, Ding JH, Bekeredjian R, Yang BZ, Shohet RV, Johnston SA et al Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci USA 2006; 103: 8469-8474.
12. Chen S, Ding JH, Grayburn PA. Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1. Gene Therapy 2007; 14: 1102-1110.
13. Hwung YP, Gu YZ, Tsai MJ. Cooperativity of sequence elementsmediates tissue specificity of the rat insulin II gene. Mol Cell Biol 1994; 4: 1784-1788.
14. Nir U, Walker MD, Rutter WJ. Regulation of rat insulin 1 gene expression: Evidence for negative regulation in nonpancreatic cells. Proc Natl Acad Sci USA 1986; 10: 3180-3184.
15. Petersen HV, Serup P, Leonard J, Michelsen BK, Madsen OD. Transcriptional regulation of the human insulin gene is dependent on the homeodomain protein STF1/IPF1 acting through the CT boxes. Proc Natl Acad Sci USA 1994; 91: 10465-10469.
16. Boam DS, Clark AR, Docherty K. Positive and negative regulation of the human insulin gene by multiple trans-acting factors. J Biol Chem 1990; 14: 8285-8296.
17. Fukazawa T, Matsuoka J, Naomoto Y, Nakai T, Durbin ML, Kojima I et al Development of a novel beta-cell specific promoter system for the identification of insulin-producing cells in in vitro cell cultures. Exp Cell Res 2006; 312: 3404-3412.
18. Walker MD, Edlund T, Boulet AM, Rutter WJ. Cell-specifi expression controlled by the 5′-flanking region of insulin and chymotrypsin genes. Nature 1983; 306: 557-561.
19. Andrali SS, Sampley ML, Vanderford NL, Ozcan S. Glucose regulation of insulin gene expression in pancreatic beta-cells. Biochem J 2008; 415: 1-10.
20. Edlund T, Walker MD, Barr PJ, Rutter WJ. Cell-specific expression of the rat insulin gene: Evidence for role of two distinct 5′ flanking elements. Science 1985; 230: 912-916.
21. German MS, Moss LG, Rutter WJ. Regulation of insulin gene expression by glucose and calcium in transfected primary islet cultures. J Biol Chem 1990; 265: 22063-22066.
22. Philippe J. Structure and pancreatic expression of the insulin and glucagon genes. Endocr Rev 1991; 12: 252-271.
23. Cordier-Bussat M, Morel C, Philippe J. Homologous DNA sequences and cellular factors are implicated in the control of glucagon and insulin gene expression. Mol Cell Biol 1995; 15: 3904-3916.
24. Olson LK. Elevated glucose attenuates human insulin gene promoter activity in INS-1 pancreatic beta-cells via reduced nuclear factor binding to the A5/core and Z element. Mol Endocrinol 2005; 19 1343-1360.
25. Gradwohl G, Dierich A, LeMeur M, Guillemot F. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 2000; 97: 1607-1611.
26. Cordle SR, Henderson E, Masuoka H, Weil PA, Stein R. Pancreatic beta-cell-type-specific transcription of the insulin gene is mediated by basic helix-loop-helix DNA-binding proteins. Mol Cell Biol 1991; 11: 1734-1738.
27. Naya FJ, Stellrecht CM, Tsai MJ. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev 1995; 9: 1009-1019.
28. Ohneda K, Mirmira R, Wang J, Johnson J, German M. The homeodomain of PDX-1 mediates multiple proteinprotein interactions in the formation of a transcriptional activation complex on the insulin gene promoter. Mol Cell Biol 2000; 20: 900-911.
29. Sussel L, Kalamaras J, Hartigan-O'Connor DJ, Meneses JJ, Pedersen RA, Rubenstein JL et al. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 1998; 12: 2213-2221.
30. Mirmira RG, Watada H, German MS. Autoregulation and maturity onset diabetes of the young transcription factors control the human PAX4 promoter. J Biol Chem 2000; 19: 14743-14751.
31. Sander M, Neubuser A, Kalamaras J, Ee HC, Martin GR, German MS. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev 1997; 13: 1662-1673.
32. German M, Ashcroft S, Docherty K, Edlund H, Edlund T, Goodison S et al. The insulin gene promoter. A simplified nomenclature. Diabetes 1995; 44: 1002-1004.
33. Boam DSW, Docherty K. A tissue specific nuclear factor binds to multiple sites in the human insulin gene enhancer. Biochem J 1989; 264 233-239.
34. Kennedy GC, Rutter WJ. Pur-1, a zinc-finger protein that binds to purin-rich sequences, transactivates an insulin promoter in heterologous cells. Proc Natl Acad Sci USA 1992; 89: 11498-11502.
35. Ohlsson H, Thor S, Edlund T. Novel insulin promoter-and enhancer-binding proteins that discriminate betwen pancreatic α- and β-cells. Mol Endocrinol 1991; 5: 897-904.
36. Cordle SR, Henderson E, Masuoka H, Weil PA, Stein R. Pancreatic [3-cell-type-specific transcription of the insulin gene is mediated by basic helix-loop-helix DNAbinding proteins. Mol Cell Biol 1991; 11: 1718-1734.